Sigma-Aldrich, SwitchGear Co-developing miRNA Target Validation System | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sigma-Aldrich and SwitchGear Genomics are partnering on a project to develop a novel microRNA target reporter system.

The collaboration announced today brings together SwitchGear's expertise and Sigma-Aldrich's lentiviral technology and is expected to result in a genome-wide collection of target vectors that will provide "highly effective miRNA target validation without the need for time-consuming and laborious reporter cloning," Sigma-Aldrich said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.